Breuil, L.; Goutal, S.; Marie, S.; Del Vecchio, A.; Audisio, D.; Soyer, A.; Goislard, M.; Saba, W.; Tournier, N.; Caillé, F.
Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging. Pharmaceutics 2022, 14, 1658.
https://doi.org/10.3390/pharmaceutics14081658
AMA Style
Breuil L, Goutal S, Marie S, Del Vecchio A, Audisio D, Soyer A, Goislard M, Saba W, Tournier N, Caillé F.
Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging. Pharmaceutics. 2022; 14(8):1658.
https://doi.org/10.3390/pharmaceutics14081658
Chicago/Turabian Style
Breuil, Louise, Sébastien Goutal, Solène Marie, Antonio Del Vecchio, Davide Audisio, Amélie Soyer, Maud Goislard, Wadad Saba, Nicolas Tournier, and Fabien Caillé.
2022. "Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging" Pharmaceutics 14, no. 8: 1658.
https://doi.org/10.3390/pharmaceutics14081658
APA Style
Breuil, L., Goutal, S., Marie, S., Del Vecchio, A., Audisio, D., Soyer, A., Goislard, M., Saba, W., Tournier, N., & Caillé, F.
(2022). Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging. Pharmaceutics, 14(8), 1658.
https://doi.org/10.3390/pharmaceutics14081658
